Company Background and Headquarters
Dame is a privately held fintech and consumer health company headquartered in New York City. The company was founded in 2016 by Alexandra Friedman and Janet Lieberman, who met at the MIT Media Lab. Dame positions itself as a direct-to-consumer brand that uses a subscription model to sell period care products, including menstrual discs, applicator-free tampons, and lubricants.
The company operates at the intersection of consumer wellness, e-commerce, and subscription commerce, with a stated mission to close the gender health gap. Dame has raised multiple funding rounds from venture capital firms, with investors including Forerunner Ventures, Lux Capital, and Union Square Ventures, as noted on its public funding announcements and press coverage.
Funding, Valuation, and Market Position
Dame has completed several venture capital rounds, with its most recent disclosed funding coming from a Series B round that brought its total capital raised to over 70 million dollars, according to reports from TechCrunch and Forbes. The company has been recognized in lists such as Forbes' 30 Under 30 and Inc. 5000, highlighting its rapid growth in the direct-to-consumer health and wellness sector.
In the competitive landscape of period care and feminine health tech, Dame competes with brands like Lola, Cora, and Thinx, while differentiating itself through its focus on design, medical-grade materials, and a subscription-first distribution model. Dame products are sold primarily through its own website and subscription service, with availability also expanding into select retail partners.
Products, Technology, and Regulatory Context
Dame's core product lines include the DAME Disc, a reusable menstrual disc made of medical-grade silicone, and a range of tampons and lubricants designed without traditional applicators. The company emphasizes FDA-compliant manufacturing, with products made in FDA-registered facilities in the United States. Dame's approach combines product design with digital subscription logistics to reduce waste and improve access.
Dame's business model relies on recurring revenue from subscriptions, with pricing tiers that vary by product frequency and selection. Customers can manage their subscriptions, skip months, or cancel through the Dame online portal. For regulatory and consumer protection context, the FDA oversees menstrual care products as medical devices and general wellness products, with guidelines available on the FDA website here.